Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs Glargine in Exercise for T1DM
NCT01440439Phase 4Unknown
- Sponsor
- Buckinghamshire Healthcare NHS Trust
- Start
- Nov 2011
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Buckinghamshire Healthcare NHS Trust. Primary endpoint: Glucose excursion during exercise at 1 hour. Status: unknown.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01440439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440439.